These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31565192)

  • 21. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor.
    Saramäki A; Banwell CM; Campbell MJ; Carlberg C
    Nucleic Acids Res; 2006; 34(2):543-54. PubMed ID: 16434701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
    Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.
    Weinberg WC; Montano NE; Deng C
    Oncogene; 1997 Aug; 15(6):685-90. PubMed ID: 9264409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells.
    Liu J; Estes ML; Drazba JA; Liu H; Prayson R; Kondo S; Jacobs BS; Barnett GH; Barna BP
    Oncogene; 2000 Feb; 19(5):661-9. PubMed ID: 10698511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of p21(waf1/cip1) expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomas.
    Schwerer MJ; Sailer A; Kraft K; Baczako K; Maier H
    J Clin Pathol; 2001 Nov; 54(11):871-6. PubMed ID: 11684723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Cyclin-dependent Kinase Inhibitor p21(WAF1/CIP1) in Non-small Cell Lung Carcinomas: Relationship with p53 Status and Proliferative Activity.
    Myong NH
    Cancer Res Treat; 2001 Aug; 33(4):329-34. PubMed ID: 26680804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites.
    Sowa Y; Orita T; Hiranabe-Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
    Ann N Y Acad Sci; 1999; 886():195-9. PubMed ID: 10667218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas.
    Hui AM; Kanai Y; Sakamoto M; Tsuda H; Hirohashi S
    Hepatology; 1997 Mar; 25(3):575-9. PubMed ID: 9049201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
    Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
    Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
    Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
    Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of nitric oxide-evoked apoptosis by the p53-downstream target p21(WAF1/CIP1).
    Yang F; von Knethen A; Brüne B
    J Leukoc Biol; 2000 Dec; 68(6):916-22. PubMed ID: 11129661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined examination of p27(Kip1), p21(Waf1/Cip1) and p53 expression allows precise estimation of prognosis in patients with gastric carcinoma.
    Liu XP; Kawauchi S; Oga A; Suehiro Y; Tsushimi K; Tsushimi M; Sasaki K
    Histopathology; 2001 Dec; 39(6):603-10. PubMed ID: 11903579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
    Craanen ME; Blok P; Offerhaus GJ; Meijer GA; Dekker W; Kuipers EJ; Meuwissen SG
    J Pathol; 1999 Dec; 189(4):481-6. PubMed ID: 10629547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance and expression of p53, p21(Cip1/WAF1) and Gadd45α in breast neoplasm tissues].
    Gao QZ; Fei BJ; Qi XW; Pu Y; Feng YZ
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2389-93. PubMed ID: 23158659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas.
    Shi YZ; Hui AM; Takayama T; Li X; Cui X; Makuuchi M
    Br J Cancer; 2000 Jul; 83(1):50-5. PubMed ID: 10883667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of p21(WAF1/CIP1) and p53 expression in serous cystadenocarcinoma of the ovary.
    Terauchi F; Okamoto A; Nagashima T; Kobayashi Y; Moritake T; Yamamoto Y; Takakura S; Iwaki S; Ogura H
    Oncol Rep; 2005 Aug; 14(2):363-8. PubMed ID: 16012716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p21Cip1/Waf1 protein and its function based on a subcellular localization [corrected].
    Cmielová J; Rezáčová M
    J Cell Biochem; 2011 Dec; 112(12):3502-6. PubMed ID: 21815189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M; Husnjak K; Körbler T; Pavelić J
    Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms.
    Wong NA; Mayer NJ; Anderson CE; McKenzie HC; Morris RG; Diebold J; Mayr D; Brock IW; Royds JA; Gilmour HM; Harrison DJ
    Hum Pathol; 2003 Jun; 34(6):580-8. PubMed ID: 12827612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.